SEC Form D · filed April 4, 2022
VenatoRx Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (29)
Timothy J. Henkel · Malvern, PAExecDaniel C. Pevear · Malvern, PAExecAnthony J. Meehan · Malvern, PAExecEzra J. Felker · Malvern, PAExecMichael C. Diem · Malvern, PADirectorTimothy J. Haines · Malvern, PADirectorChristopher J. Burns · Malvern, PAExec · DirectorMartin J. Heidecker · Malvern, PADirectorSergei J. Petukhov · Malvern, PADirectorVincent J. Milano · Malvern, PADirectorJeffrey H. Gould · Great Neck, NYExecAndrew Firman · Dallas, TXDirectorPromus Equity Partners, LLC · Chicago, ILDirectorHuber Klaus · denvor, CODirectorIsaac H. Kalish · Great Neck, NYExecMatthew H. Gould · Great Neck, NYExecSteven H. Rosenzweig · Great Neck, NYDirectorBenjamin H. Bolanos · Great Neck, NYExecWyatt Cavalier · Wilmington, DEExec · DirectorMatt M. Whelan · Long Island City, NYDirectorDavid M. Langer · Long Island City, NYExec · DirectorJohn Evans Jr · Wesley Chapel, FLDirectorClay Brock · Wilmette, ILDirectorO'Meara Lauren · Franklin, TNExecOrin Wolf · NEW YORK, NYExecArabella FCRE Management, LLC · Alpharetta, GAExecJeff J. Seavey · Houston, TXDirectorJohn Uhlein · New York, NYExecVincent J. Milano · Malvern, PADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗